T. Kellerman

Randomized pharmacokinetic evaluation of different rifabutin doses in African HIV- infected tuberculosis patients on lopinavir/ritonavir-based antiretroviral therapy

A. Harries, C. Connolly, S. Naiker, 2014, BMC Pharmacology and Toxicology.

Effect of SLCO1B1 Polymorphisms on Rifabutin Pharmacokinetics in African HIV-Infected Patients with Tuberculosis

A. Owen, S. Naiker, S. Hennig, 2015, Antimicrobial Agents and Chemotherapy.

Neurospecificity of phyto-bufadienolides is not related to differences in Na+K+ pump inhibition

F. Verdonck, E. Carmeliet, T. Kellerman, 1997 .